Table 4.
Germline mutation | |||
---|---|---|---|
SDHx (n = 13) | NI (n = 9) | P | |
Gender, n (%) | |||
Female | 3 (23) | 5 (56) | .187 |
Age (median, range) | 34 (11-49) | 42 (13-50) | .471 |
Presentation, n (%) | |||
HTN | 11 (85) | 9 (100) | .494 |
Headache | 5 (39) | 5 (56) | 0.666 |
Palpitation | 8 (62) | 4 (44) | 0.666 |
Perspiration | 6 (46) | 5 (56) | 1 |
Chest pain | 3 (23) | 0 (0) | .24 |
Multiple PPGLs, n (%) | 7 (54) | 3 (33) | .415 |
Metastasis, n (%) | 1 (8) | 1 (11) | 1 |
Family history, n (%) | 4 (31) | 0 (0) | .002 |
Urinary CA elevationa, n (%) | |||
Norepinephrine | 12 (100) | 8 (89) | .429 |
Epinephrine | 2 (17) | 4 (44) | .331 |
Dopamine | 8 (67) | 5 (56) | .673 |
MTD (cm) (median, range) | 5.5 (3.5-8.0) | 5.0 (3.0-7.5) | .601 |
Ki-67 index ≥ 3%a, n (%) | 5 (42) | 5 (56) | .67 |
Abbreviations: CA, catecholamine; HTN, hypertension; MTD, maximum tumor diameter; NI, not identified; PPGLs, pheochromocytomas and paragangliomas; SDHx, succinate dehydrogenase subunits.
Urinary CA and Ki-67 index were measured in 12 patients with SDHx mutation.